Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ALBIREO PHARMA, INC.Listing unverified | Sell | $10.7M | SEC | ||
Regulus Therapeutics Inc.Listing unverified | Sell | $34M | SEC |